首页 > 最新文献

Exploratory research in clinical and social pharmacy最新文献

英文 中文
Assessing community antibiotic usage and adherence as per standard treatment guidelines: A potential area to enhance awareness at community pharmacy settings 根据标准治疗指南评估社区抗生素使用和依从性:提高社区药房认识的一个潜在领域。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-12-12 DOI: 10.1016/j.rcsop.2024.100552
Abdullah Al Masud , Ramesh Lahiru Walpola , Malabika Sarker , Alamgir Kabir , Muhammad Asaduzzaman , Md Saiful Islam , Ayesha Tasnim Mostafa , Zubair Akhtar , Holly Seale

Background

Antibiotic nonadherence significantly contributes to poor treatment outcomes and antimicrobial resistance. In Southeast Asia, including Bangladesh, community pharmacies are crucial in primary healthcare, and are key sources of over-the-counter antibiotics. However, understanding of adherence to the full course of community-dispensed antibiotics is limited. This study measured antibiotic adherence to Bangladesh government and WHO Standard Treatment Guidelines (STGs) among patients at community pharmacies and identifies associated factors.

Methods

A cross-sectional survey was conducted via phone among 358 respondents from four urban and rural areas of Bangladesh who participated in a previous antibiotic purchasing behavior survey. Descriptive analysis identified antibiotic use patterns, and adherence to the full course of antibiotics was assessed against STGs recommendations. Poisson regression model was used to explore correlations between patients' demographic characteristics, knowledge of antibiotic dosage, dosage regimen, and type of health-symptoms and adherence to the full course of antibiotics.

Results

Adherence to antibiotic dosage per STGs was 40.5 %. Patients consulting a registered medical practitioner were significantly more likely to adhere (Adj-PR: 3.81, 95 % CI: 2.82–5.14) compared to those who did not. Males were 32.0 % less likely to adhere than females (Adj-PR: 0.68, 95 % CI: 0.54–0.86). Rural residents demonstrated 37.0 % lower adherence compared to urban (Adj- PR: 0.63, 95 % CI: 0.45–0.87). Respondents who recalled the antibiotic dosage had a higher likelihood of adherence (Adj-PR: 2.04, 95 % CI: 1.06–3.93). Patients on 12-hourly regimens had higher adherence (Adj-PR: 1.55, 95 % CI: 1.03–2.33) than 6-hourly regimens. Patients with uncomplicated skin-infections had higher adherence (Adj-PR: 1.72, 95 % CI: 1.22–2.47), while other symptoms showed no significant association.

Conclusion

Targeted interventions in diverse healthcare settings are essential, including user-centric research and enhancing patient knowledge and involvement. Strengthening patient-physician relationships and involving community pharmacies in antimicrobial stewardship programs can improve antibiotic dispensing and counselling practices among drug-sellers.
背景:不坚持使用抗生素是导致治疗效果不佳和抗生素耐药性的重要原因。在包括孟加拉国在内的东南亚地区,社区药房对初级医疗保健至关重要,也是非处方药抗生素的主要来源。然而,人们对社区发放的抗生素整个疗程的依从性了解有限。本研究测量了社区药房患者对孟加拉国政府和世界卫生组织《标准治疗指南》(STGs)的抗生素依从性,并确定了相关因素:通过电话对来自孟加拉国四个城市和农村地区的 358 名受访者进行了横断面调查,这些受访者曾参加过抗生素购买行为调查。描述性分析确定了抗生素的使用模式,并根据 STGs 建议评估了抗生素全疗程的依从性。采用泊松回归模型探讨了患者的人口统计学特征、抗生素剂量知识、剂量方案和健康症状类型与坚持使用全疗程抗生素之间的相关性:结果:按照 STGs 遵循抗生素剂量的比例为 40.5%。与未向注册医生咨询的患者相比,向注册医生咨询的患者更有可能坚持使用抗生素(Adj-PR:3.81,95 % CI:2.82-5.14)。男性坚持治疗的可能性比女性低 32.0%(Adj-PR:0.68,95 % CI:0.54-0.86)。农村居民的依从性比城市居民低 37.0%(Adj- PR:0.63,95 % CI:0.45-0.87)。回忆起抗生素剂量的受访者更有可能坚持用药(Adj-PR:2.04,95 % CI:1.06-3.93)。与 6 小时疗程相比,12 小时疗程患者的依从性更高(Adj-PR:1.55,95 % CI:1.03-2.33)。无并发症皮肤感染患者的依从性更高(Adj-PR:1.72,95 % CI:1.22-2.47),而其他症状则无明显关联:结论:在不同的医疗环境中采取有针对性的干预措施至关重要,其中包括以用户为中心的研究以及增强患者的知识和参与。加强患者与医生之间的关系并让社区药房参与抗菌药物管理项目,可以改善药品销售人员的抗生素配发和咨询行为。
{"title":"Assessing community antibiotic usage and adherence as per standard treatment guidelines: A potential area to enhance awareness at community pharmacy settings","authors":"Abdullah Al Masud ,&nbsp;Ramesh Lahiru Walpola ,&nbsp;Malabika Sarker ,&nbsp;Alamgir Kabir ,&nbsp;Muhammad Asaduzzaman ,&nbsp;Md Saiful Islam ,&nbsp;Ayesha Tasnim Mostafa ,&nbsp;Zubair Akhtar ,&nbsp;Holly Seale","doi":"10.1016/j.rcsop.2024.100552","DOIUrl":"10.1016/j.rcsop.2024.100552","url":null,"abstract":"<div><h3>Background</h3><div>Antibiotic nonadherence significantly contributes to poor treatment outcomes and antimicrobial resistance. In Southeast Asia, including Bangladesh, community pharmacies are crucial in primary healthcare, and are key sources of over-the-counter antibiotics. However, understanding of adherence to the full course of community-dispensed antibiotics is limited. This study measured antibiotic adherence to Bangladesh government and WHO Standard Treatment Guidelines (STGs) among patients at community pharmacies and identifies associated factors.</div></div><div><h3>Methods</h3><div>A cross-sectional survey was conducted via phone among 358 respondents from four urban and rural areas of Bangladesh who participated in a previous antibiotic purchasing behavior survey. Descriptive analysis identified antibiotic use patterns, and adherence to the full course of antibiotics was assessed against STGs recommendations. Poisson regression model was used to explore correlations between patients' demographic characteristics, knowledge of antibiotic dosage, dosage regimen, and type of health-symptoms and adherence to the full course of antibiotics.</div></div><div><h3>Results</h3><div>Adherence to antibiotic dosage per STGs was 40.5 %. Patients consulting a registered medical practitioner were significantly more likely to adhere (Adj-PR: 3.81, 95 % CI: 2.82–5.14) compared to those who did not. Males were 32.0 % less likely to adhere than females (Adj-PR: 0.68, 95 % CI: 0.54–0.86). Rural residents demonstrated 37.0 % lower adherence compared to urban (Adj- PR: 0.63, 95 % CI: 0.45–0.87). Respondents who recalled the antibiotic dosage had a higher likelihood of adherence (Adj-PR: 2.04, 95 % CI: 1.06–3.93). Patients on 12-hourly regimens had higher adherence (Adj-PR: 1.55, 95 % CI: 1.03–2.33) than 6-hourly regimens. Patients with uncomplicated skin-infections had higher adherence (Adj-PR: 1.72, 95 % CI: 1.22–2.47), while other symptoms showed no significant association.</div></div><div><h3>Conclusion</h3><div>Targeted interventions in diverse healthcare settings are essential, including user-centric research and enhancing patient knowledge and involvement. Strengthening patient-physician relationships and involving community pharmacies in antimicrobial stewardship programs can improve antibiotic dispensing and counselling practices among drug-sellers.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"17 ","pages":"Article 100552"},"PeriodicalIF":1.8,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11731586/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142985533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors influencing E-pharmacy adoption in India: A study of user experiences through interpretative phenomenological analysis
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-12-12 DOI: 10.1016/j.rcsop.2024.100550
Kushal Pal Singh, Pawan Kumar
The rapid growth of e-commerce has led to the emergence of e-pharmacies, which enable consumers to purchase prescription medications online. This study aims to explore the factors influencing the adoption of e-pharmacies in India through an interpretative phenomenological analysis (IPA) approach. Twelve in-depth interviews were conducted with individuals who had experience ordering prescription medicines through e-pharmacies. The findings revealed that constructs from the UTAUT2 model, including performance expectancy, effort expectancy, social influence, facilitating conditions, price value, and habit, played a significant role in the adoption of e-pharmacies. Construct hedonic motivation, from UTAUT2, was found to be weakly significant in explaining the adoption of e-pharmacy. Additionally, health literacy was identified as a key factor, with e-pharmacy users demonstrating higher levels of health literacy. However, perceived risks, such as performance, financial, privacy, and psychological risks, were found to negatively influence the adoption of e-pharmacies. The study proposes, based on findings, a research model to understand consumer behavior in the adoption of e-pharmacies. The findings suggest that the presence of favorable conditions, such as convenience, accessibility, user-friendly interfaces, social influence, internet accessibility, integrated healthcare services, diverse payment methods, and price advantages, have contributed to the widespread acceptance and adoption of e-pharmacy services in India. The study highlights the need for future research to employ quantitative or mixed methods approaches to address the limitations of the current exploratory study and to investigate the multifaceted determinants of e-pharmacy adoption in different geographical contexts.
{"title":"Factors influencing E-pharmacy adoption in India: A study of user experiences through interpretative phenomenological analysis","authors":"Kushal Pal Singh,&nbsp;Pawan Kumar","doi":"10.1016/j.rcsop.2024.100550","DOIUrl":"10.1016/j.rcsop.2024.100550","url":null,"abstract":"<div><div>The rapid growth of e-commerce has led to the emergence of e-pharmacies, which enable consumers to purchase prescription medications online. This study aims to explore the factors influencing the adoption of e-pharmacies in India through an interpretative phenomenological analysis (IPA) approach. Twelve in-depth interviews were conducted with individuals who had experience ordering prescription medicines through e-pharmacies. The findings revealed that constructs from the UTAUT2 model, including performance expectancy, effort expectancy, social influence, facilitating conditions, price value, and habit, played a significant role in the adoption of e-pharmacies. Construct hedonic motivation, from UTAUT2, was found to be weakly significant in explaining the adoption of e-pharmacy. Additionally, health literacy was identified as a key factor, with e-pharmacy users demonstrating higher levels of health literacy. However, perceived risks, such as performance, financial, privacy, and psychological risks, were found to negatively influence the adoption of e-pharmacies. The study proposes, based on findings, a research model to understand consumer behavior in the adoption of e-pharmacies. The findings suggest that the presence of favorable conditions, such as convenience, accessibility, user-friendly interfaces, social influence, internet accessibility, integrated healthcare services, diverse payment methods, and price advantages, have contributed to the widespread acceptance and adoption of e-pharmacy services in India. The study highlights the need for future research to employ quantitative or mixed methods approaches to address the limitations of the current exploratory study and to investigate the multifaceted determinants of e-pharmacy adoption in different geographical contexts.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"17 ","pages":"Article 100550"},"PeriodicalIF":1.8,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11788603/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143123972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing work in community pharmacy: What preferences do community pharmacists and pharmacy technicians have for a better allocation of daily activities? 优化社区药房工作:社区药剂师和药学技术人员对更好地分配日常活动有什么偏好?
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-12-11 DOI: 10.1016/j.rcsop.2024.100549
Jean-Didier Bardet , Jérôme Combe , Arnaud Tanty , Perrine Louvier , Mathieu Granjon , Benoît Allenet

Objective

Pharmacy work encompasses two main streams. These are logistic flow (the supply and distribution of healthcare products) and pharmaceutical flow (the dispensing and provision of pharmacy services). The pharmaceutical flow has increased significantly with the introduction of reimbursed services such as Rapid Diagnostic Tests, chronic disease screening, minor ailment prescriptions, vaccine prescription and administration, and medication reviews. The implementation of new pharmacy services requires efficiency. The main objective of the survey presented here was to determine the preferences of community pharmacists and pharmacy technicians in relation to the assignment of tasks within the community pharmacy team.

Method

The survey, which used the Best-Worst Scaling (BWS) method, presented 13 daily pharmacy activities to community pharmacists (CPs) and pharmacy technicians (PTs). Descriptive statistics and Bayesian logistic regression were used to analyse the data.

Key findings

The results indicate that medication dispensing is a shared activity between CPs and PTs, for which the latter already have partial autonomy. Management of nursing home orders and supplies tends to be assigned to pharmacy technicians, whereas clinical pharmacy services such as prescription renewal, medication reviews, and counselling are considered to be more within the CPs' domain. CPs would readily delegate tasks like screening procedures to PTs. PTs express interest in minor ailment prescribing, a responsibility CPs are not yet ready to entrust to them.

Conclusions

Delegating logistical activities to pharmacy technicians could enable community pharmacists to focus on specialized pharmaceutical care, thereby improving the efficiency and quality of the services offered to patients. However, the reorganization of tasks should not only be implemented from a logistical standpoint since pharmacy technicians also share an interest in pharmaceutical care.
目的:药学工作包括两大主流。这些是物流流(保健产品的供应和分配)和药品流(配药和提供药房服务)。由于采用了诸如快速诊断测试、慢性病筛查、小病处方、疫苗处方和给药以及药物审查等报销服务,药品流量大大增加。实施新的药房服务需要效率。本次调查的主要目的是确定社区药剂师和药学技术人员在社区药学团队任务分配方面的偏好。方法:采用最佳最差评分法(Best-Worst scale, BWS)对社区药师(CPs)和药学技术人员(PTs)的13项日常药学活动进行问卷调查。采用描述性统计和贝叶斯逻辑回归对数据进行分析。主要发现:结果表明,配药是CPs和PTs之间的共同活动,后者已经有部分自主权。养老院订单和供应的管理往往分配给药学技术人员,而临床药学服务,如处方更新、药物审查和咨询,则被认为更多地属于CPs的领域。CPs会很容易地将筛查程序等任务委托给PTs。PTs表达了对小病处方的兴趣,这是CPs尚未准备好委托给他们的责任。结论:将后勤工作委托给药学技术人员,可使社区药师专注于专科药学服务,从而提高为患者提供服务的效率和质量。然而,任务的重组不应该仅仅从后勤的角度来实施,因为药学技术人员也对药学服务感兴趣。
{"title":"Optimizing work in community pharmacy: What preferences do community pharmacists and pharmacy technicians have for a better allocation of daily activities?","authors":"Jean-Didier Bardet ,&nbsp;Jérôme Combe ,&nbsp;Arnaud Tanty ,&nbsp;Perrine Louvier ,&nbsp;Mathieu Granjon ,&nbsp;Benoît Allenet","doi":"10.1016/j.rcsop.2024.100549","DOIUrl":"10.1016/j.rcsop.2024.100549","url":null,"abstract":"<div><h3>Objective</h3><div>Pharmacy work encompasses two main streams. These are logistic flow (the supply and distribution of healthcare products) and pharmaceutical flow (the dispensing and provision of pharmacy services). The pharmaceutical flow has increased significantly with the introduction of reimbursed services such as Rapid Diagnostic Tests, chronic disease screening, minor ailment prescriptions, vaccine prescription and administration, and medication reviews. The implementation of new pharmacy services requires efficiency. The main objective of the survey presented here was to determine the preferences of community pharmacists and pharmacy technicians in relation to the assignment of tasks within the community pharmacy team.</div></div><div><h3>Method</h3><div>The survey, which used the Best-Worst Scaling (BWS) method, presented 13 daily pharmacy activities to community pharmacists (CPs) and pharmacy technicians (PTs). Descriptive statistics and Bayesian logistic regression were used to analyse the data.</div></div><div><h3>Key findings</h3><div>The results indicate that medication dispensing is a shared activity between CPs and PTs, for which the latter already have partial autonomy. Management of nursing home orders and supplies tends to be assigned to pharmacy technicians, whereas clinical pharmacy services such as prescription renewal, medication reviews, and counselling are considered to be more within the CPs' domain. CPs would readily delegate tasks like screening procedures to PTs. PTs express interest in minor ailment prescribing, a responsibility CPs are not yet ready to entrust to them.</div></div><div><h3>Conclusions</h3><div>Delegating logistical activities to pharmacy technicians could enable community pharmacists to focus on specialized pharmaceutical care, thereby improving the efficiency and quality of the services offered to patients. However, the reorganization of tasks should not only be implemented from a logistical standpoint since pharmacy technicians also share an interest in pharmaceutical care.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"17 ","pages":"Article 100549"},"PeriodicalIF":1.8,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11733183/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug utilisation research and medicine access in Mozambique: An overview 莫桑比克的药物利用研究和药物获取:综述。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-12-07 DOI: 10.1016/j.rcsop.2024.100548
Roger Wiseman , Ilse Truter
Access to medicine is fundamental to the provision of equitable health systems. However, availability of affordable quality-assured medicines continues to be poor, especially in Low- and Middle-Income Countries (LMICs). Targeted efforts associated with transparency and accountability around medicine utilisation are required in LMICs to address this problem. With the increased global focus on improved access to medicines, there is a heightened imperative to understand the current landscape of medicine prescribing in these territories. In Sub-Saharan Africa, drug utilisation research is generally under-developed due to the lack of access to databases that capture prescribed drug utilisation information. The advent of private health insurance in many African countries, including Mozambique, where the average life expectancy at birth is of the lowest in Sub-Saharan Africa, has created an opportunity to collect comprehensive medicine-related prescription data to facilitate monitoring and evaluation of medicine use thereby assisting in directing medicine-related policy. This overview focuses on Mozambique as one such country where future drug utilisation studies might assist in informing medicine-related health policy and improving medicine access. In addition, it explores drug utilisation as a research methodology and how it might be of assistance in meeting Mozambique's unmet needs.
获得药品对于提供公平的卫生系统至关重要。然而,负担得起的有质量保证的药品的可得性仍然很差,特别是在低收入和中等收入国家。为了解决这一问题,中低收入国家需要有针对性地努力提高药品使用的透明度和问责制。随着全球对改善药物可及性的日益重视,更加迫切需要了解这些地区目前的药物处方情况。在撒哈拉以南非洲,由于缺乏获取处方药利用信息的数据库,药物利用研究通常不发达。在许多非洲国家,包括出生时平均预期寿命是撒哈拉以南非洲最低的莫桑比克,私营医疗保险的出现创造了一个机会,可以收集与药品有关的全面处方数据,以促进对药品使用情况的监测和评价,从而协助指导与药品有关的政策。本综述的重点是莫桑比克作为这样一个国家,未来的药物利用研究可能有助于为与医学有关的卫生政策提供信息和改善药物获取。此外,它还探讨了药物利用作为一种研究方法,以及它如何有助于满足莫桑比克尚未满足的需求。
{"title":"Drug utilisation research and medicine access in Mozambique: An overview","authors":"Roger Wiseman ,&nbsp;Ilse Truter","doi":"10.1016/j.rcsop.2024.100548","DOIUrl":"10.1016/j.rcsop.2024.100548","url":null,"abstract":"<div><div>Access to medicine is fundamental to the provision of equitable health systems. However, availability of affordable quality-assured medicines continues to be poor, especially in Low- and Middle-Income Countries (LMICs). Targeted efforts associated with transparency and accountability around medicine utilisation are required in LMICs to address this problem. With the increased global focus on improved access to medicines, there is a heightened imperative to understand the current landscape of medicine prescribing in these territories. In Sub-Saharan Africa, drug utilisation research is generally under-developed due to the lack of access to databases that capture prescribed drug utilisation information. The advent of private health insurance in many African countries, including Mozambique, where the average life expectancy at birth is of the lowest in Sub-Saharan Africa, has created an opportunity to collect comprehensive medicine-related prescription data to facilitate monitoring and evaluation of medicine use thereby assisting in directing medicine-related policy. This overview focuses on Mozambique as one such country where future drug utilisation studies might assist in informing medicine-related health policy and improving medicine access. In addition, it explores drug utilisation as a research methodology and how it might be of assistance in meeting Mozambique's unmet needs.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"17 ","pages":"Article 100548"},"PeriodicalIF":1.8,"publicationDate":"2024-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11699339/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142933995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacist-led Si-care (schizophrenia care) model to improve medication adherence and symptom management in schizophrenia 药师主导的Si-care(精神分裂症护理)模式改善精神分裂症患者的服药依从性和症状管理
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-12-01 DOI: 10.1016/j.rcsop.2024.100544
Noor Cahaya , Susi Ari Kristina , Anna Wahyuni Widayanti , James A. Green

Introduction

Schizophrenia is a chronic mental disorder that requires long-term treatment, particularly antipsychotic medications. However, medication adherence among patients with schizophrenia is often suboptimal, leading to symptom relapse and poor outcomes. The Si-Care (Schizophrenia Care) program was developed as a pharmacist-led home intervention to improve medication adherence and support symptom control in patients with schizophrenia. This study aimed to evaluate the effectiveness of the Si-Care intervention in improving medication adherence and maintaining stability of symptoms among schizophrenia patients.

Methods

A quasi-experimental study was conducted in three community health centers or Puskesmas in Banjarmasin, Indonesia. A total of 57 participants were recruited according to the sampling criteria. The Si-Care intervention consisted of seven home visits by trained pharmacists over four months, providing education, counseling, and medication monitoring. Adherence to medication was evaluated using the pill count method and severity of symptoms was measured using the Positive and Negative Syndrome Scale (PANSS) pre- and post-intervention. Data were analyzed using the Friedman test for adherence and the Wilcoxon test for PANSS scores.

Results

Mean medication adherence improved significantly from 77.38 % ± 25.85 at baseline (T0) to 97.57 % ± 11.09 at the final visit (T4) (p = 0.000). However, the decrease in PANSS scores from 38.03 ± 9.14 to 37.81 ± 9.15 was not statistically significant (p = 0.089). Despite the lack of significant change in PANSS scores, symptoms remained stable throughout the intervention, suggesting effective symptom management.

Conclusions

The Si-Care intervention significantly improved medication adherence among people with schizophrenia, contributing to the maintenance of stable symptoms. Pharmacist-led home interventions provide valuable support to address adherence challenges and should be considered a critical component in schizophrenia care. Future studies should consider a more rigorous design, a larger sample size, and longer follow-up to better evaluate the sustainability, scalability, and applicability of the intervention in diverse healthcare settings.
精神分裂症是一种慢性精神障碍,需要长期治疗,特别是抗精神病药物。然而,精神分裂症患者的药物依从性往往不理想,导致症状复发和预后不良。Si-Care(精神分裂症护理)项目是一种药剂师主导的家庭干预,旨在改善精神分裂症患者的药物依从性并支持症状控制。本研究旨在评估Si-Care干预在改善精神分裂症患者服药依从性和维持症状稳定性方面的有效性。方法在印度尼西亚班加马辛市3个社区卫生中心(Puskesmas)进行准实验研究。根据抽样标准,共招募了57名参与者。Si-Care干预包括由训练有素的药剂师在四个月内进行七次家访,提供教育、咨询和药物监测。使用药片计数法评估药物依从性,使用阳性和阴性综合征量表(PANSS)测量干预前后症状的严重程度。使用Friedman测试依从性和Wilcoxon测试PANSS分数来分析数据。结果平均服药依从性由基线(T0)时的77.38%±25.85改善至末次访时(T4)时的97.57%±11.09 (p = 0.000)。PANSS评分由38.03±9.14降至37.81±9.15,差异无统计学意义(p = 0.089)。尽管PANSS评分没有明显变化,但在整个干预过程中症状保持稳定,表明有效的症状管理。结论Si-Care干预显著提高了精神分裂症患者的药物依从性,有助于维持症状的稳定。药剂师主导的家庭干预为解决依从性挑战提供了宝贵的支持,应被视为精神分裂症护理的关键组成部分。未来的研究应考虑更严格的设计、更大的样本量和更长的随访,以更好地评估干预在不同医疗保健环境中的可持续性、可扩展性和适用性。
{"title":"Pharmacist-led Si-care (schizophrenia care) model to improve medication adherence and symptom management in schizophrenia","authors":"Noor Cahaya ,&nbsp;Susi Ari Kristina ,&nbsp;Anna Wahyuni Widayanti ,&nbsp;James A. Green","doi":"10.1016/j.rcsop.2024.100544","DOIUrl":"10.1016/j.rcsop.2024.100544","url":null,"abstract":"<div><h3>Introduction</h3><div>Schizophrenia is a chronic mental disorder that requires long-term treatment, particularly antipsychotic medications. However, medication adherence among patients with schizophrenia is often suboptimal, leading to symptom relapse and poor outcomes. The Si-Care (Schizophrenia Care) program was developed as a pharmacist-led home intervention to improve medication adherence and support symptom control in patients with schizophrenia. This study aimed to evaluate the effectiveness of the Si-Care intervention in improving medication adherence and maintaining stability of symptoms among schizophrenia patients.</div></div><div><h3>Methods</h3><div>A quasi-experimental study was conducted in three community health centers or Puskesmas in Banjarmasin, Indonesia. A total of 57 participants were recruited according to the sampling criteria. The Si-Care intervention consisted of seven home visits by trained pharmacists over four months, providing education, counseling, and medication monitoring. Adherence to medication was evaluated using the pill count method and severity of symptoms was measured using the Positive and Negative Syndrome Scale (PANSS) pre- and post-intervention. Data were analyzed using the Friedman test for adherence and the Wilcoxon test for PANSS scores.</div></div><div><h3>Results</h3><div>Mean medication adherence improved significantly from 77.38 % ± 25.85 at baseline (T0) to 97.57 % ± 11.09 at the final visit (T4) (<em>p</em> = 0.000). However, the decrease in PANSS scores from 38.03 ± 9.14 to 37.81 ± 9.15 was not statistically significant (<em>p</em> = 0.089). Despite the lack of significant change in PANSS scores, symptoms remained stable throughout the intervention, suggesting effective symptom management.</div></div><div><h3>Conclusions</h3><div>The Si-Care intervention significantly improved medication adherence among people with schizophrenia, contributing to the maintenance of stable symptoms. Pharmacist-led home interventions provide valuable support to address adherence challenges and should be considered a critical component in schizophrenia care. Future studies should consider a more rigorous design, a larger sample size, and longer follow-up to better evaluate the sustainability, scalability, and applicability of the intervention in diverse healthcare settings.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"16 ","pages":"Article 100544"},"PeriodicalIF":1.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142745716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence in community pharmacy practice: Pharmacists' perceptions, willingness to utilize, and barriers to implementation 社区药房实践中的人工智能:药剂师的认知、使用意愿和实施障碍
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-12-01 DOI: 10.1016/j.rcsop.2024.100542
Ashenafi Kibret Sendekie , Liknaw Workie Limenh , Biruk Beletew Abate , Gashaw Sisay Chanie , Abebe Tarekegn Kassaw , Fasil Bayafers Tamene , Kalab Yigermal Gete , Ephrem Mebratu Dagnew

Background

Artificial intelligence (AI) has a significant potential to impact pharmacy practices worldwide. This study investigates pharmacists' perceptions of AI's role in pharmacy practices, their willingness to adopt it, and perceived barriers to its implementation at community pharmacies in Ethiopia.

Methods

A cross-sectional study was conducted among community pharmacists in Ethiopia. Data were collected using a self-administered questionnaire. Independent samples t-test, one-way ANOVA, and post-hoc analyses were used to compare pharmacists' perception and willingness scores. A linear regression analysis examined the association of independent variables with pharmacists' perception of AI and willingness to utilize AI. A p-value <0.05 was considered statistically significant.

Results

Of 241 pharmacists approached, 225 (93.3 %) completed the survey. Overall, about two-thirds (67.1 % and 66.2 %) of community pharmacists had a high level of perception and willingness to use AI applications in pharmacy, respectively. Pharmacists with bachelor's degrees and above (β = 2.76: 95 % CI: 0.09, 5.01 vs. β = 1.79: 95 % CI: 0.05, 4.21), those who utilized scientific drug information sources (β = 2.45, 95 %: 0.17, 4.45 vs. β = 1.76, 95 % CI: 0.91, 3.89), pharmacists who had a previous exposure of AI (β = 1.02, 95 %: 0.03, 3.24 vs. β =1.13, 95 % CI: 0.07, 2.93), and those who with higher perceived AI knowledge (β =1.09, 95 % CI: 0.02, 2.46 vs. β = 1.14, 95 %CI: 0.17, 3.11) had significantly higher perception of AI and willingness to utilize it, respectively compared to their counterparts. Lack of internet availability (89.3 %), lack of AI-related software/hardware (88.2 %), and limited training (80.9 %) were the most frequently reported barriers by pharmacists to AI adoption. Over 90 % of pharmacists agreed on the importance of internet availability (93.3 %), policies/frameworks (91.6 %), and research/learning from others (89.3 %) for successful AI integration.

Conclusion

Despite positive perceptions and willingness from pharmacists, AI implementation in community pharmacies could be hindered by resource limitations, training gaps, skill constraints, and infrastructure issues. To facilitate adoption, enhancing knowledge and skills, and developing policies/frameworks are crucial.
人工智能(AI)具有影响全球药学实践的巨大潜力。本研究调查了药剂师对人工智能在药房实践中的作用的看法,他们采用人工智能的意愿,以及在埃塞俄比亚社区药房实施人工智能的障碍。方法对埃塞俄比亚社区药师进行横断面调查。数据是通过自我管理的问卷收集的。采用独立样本t检验、单因素方差分析和事后分析比较药师的感知和意愿得分。线性回归分析检验了自变量与药剂师对人工智能的认知和使用人工智能的意愿之间的关系。p值<;0.05被认为具有统计学意义。结果241名受访药师中,有225名(93.3%)完成了调查。总体而言,约三分之二(67.1%和66.2%)的社区药剂师分别对在药学中使用人工智能应用有很高的认知和意愿。药剂师拥有学士学位及以上(β= 2.76,95% CI: 0.09、5.01与β= 1.79:95%置信区间:0.05 - 4.21),那些利用科学药物信息来源(β= 2.45,95%:0.17,4.45和β= 1.76,95% CI: 0.91, 3.89),药剂师之前曝光的AI(β= 1.02,95%:0.03,3.24和β= 1.13,95% CI: 0.07, 2.93),以及那些认为更高的人工智能知识(β= 1.09,95% CI: 0.02、2.46与β= 1.14,95%置信区间CI:0.17, 3.11)对人工智能的认知和使用意愿显著高于同行。缺乏互联网可用性(89.3%)、缺乏与人工智能相关的软件/硬件(88.2%)和有限的培训(80.9%)是药剂师最常报告的采用人工智能的障碍。超过90%的药剂师同意互联网可用性(93.3%)、政策/框架(91.6%)和研究/向他人学习(89.3%)对成功整合人工智能的重要性。结论尽管药师有积极的认知和意愿,但人工智能在社区药房的实施可能会受到资源限制、培训差距、技能限制和基础设施问题的阻碍。为促进采用,加强知识和技能以及制定政策/框架至关重要。
{"title":"Artificial intelligence in community pharmacy practice: Pharmacists' perceptions, willingness to utilize, and barriers to implementation","authors":"Ashenafi Kibret Sendekie ,&nbsp;Liknaw Workie Limenh ,&nbsp;Biruk Beletew Abate ,&nbsp;Gashaw Sisay Chanie ,&nbsp;Abebe Tarekegn Kassaw ,&nbsp;Fasil Bayafers Tamene ,&nbsp;Kalab Yigermal Gete ,&nbsp;Ephrem Mebratu Dagnew","doi":"10.1016/j.rcsop.2024.100542","DOIUrl":"10.1016/j.rcsop.2024.100542","url":null,"abstract":"<div><h3>Background</h3><div>Artificial intelligence (AI) has a significant potential to impact pharmacy practices worldwide. This study investigates pharmacists' perceptions of AI's role in pharmacy practices, their willingness to adopt it, and perceived barriers to its implementation at community pharmacies in Ethiopia.</div></div><div><h3>Methods</h3><div>A cross-sectional study was conducted among community pharmacists in Ethiopia. Data were collected using a self-administered questionnaire. Independent samples <em>t</em>-test, one-way ANOVA, and post-hoc analyses were used to compare pharmacists' perception and willingness scores. A linear regression analysis examined the association of independent variables with pharmacists' perception of AI and willingness to utilize AI. A <em>p</em>-value &lt;0.05 was considered statistically significant.</div></div><div><h3>Results</h3><div>Of 241 pharmacists approached, 225 (93.3 %) completed the survey. Overall, about two-thirds (67.1 % and 66.2 %) of community pharmacists had a high level of perception and willingness to use AI applications in pharmacy, respectively. Pharmacists with bachelor's degrees and above (β = 2.76: 95 % CI: 0.09, 5.01 vs. β = 1.79: 95 % CI: 0.05, 4.21), those who utilized scientific drug information sources (β = 2.45, 95 %: 0.17, 4.45 vs. β = 1.76, 95 % CI: 0.91, 3.89), pharmacists who had a previous exposure of AI (β = 1.02, 95 %: 0.03, 3.24 vs. β =1.13, 95 % CI: 0.07, 2.93), and those who with higher perceived AI knowledge (β =1.09, 95 % CI: 0.02, 2.46 vs. β = 1.14, 95 %CI: 0.17, 3.11) had significantly higher perception of AI and willingness to utilize it, respectively compared to their counterparts. Lack of internet availability (89.3 %), lack of AI-related software/hardware (88.2 %), and limited training (80.9 %) were the most frequently reported barriers by pharmacists to AI adoption. Over 90 % of pharmacists agreed on the importance of internet availability (93.3 %), policies/frameworks (91.6 %), and research/learning from others (89.3 %) for successful AI integration.</div></div><div><h3>Conclusion</h3><div>Despite positive perceptions and willingness from pharmacists, AI implementation in community pharmacies could be hindered by resource limitations, training gaps, skill constraints, and infrastructure issues. To facilitate adoption, enhancing knowledge and skills, and developing policies/frameworks are crucial.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"16 ","pages":"Article 100542"},"PeriodicalIF":1.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142745717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmaceutical industry use of key opinion leaders to market prescription opioids: A review of internal industry documents 制药业利用关键意见领袖推销处方阿片类药物:对内部行业文件的审查
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-12-01 DOI: 10.1016/j.rcsop.2024.100543
Brian Gac , Kgosi Tavares , Hanna Yakubi , Hannah Khan , Dorie E. Apollonio , Eric Crosbie

Objective

Prescription opioid-related deaths increased by 200 % from 2000 to 2014. There has been limited research regarding channels used by pharmaceutical companies to market prescription opioids. In this study, we investigated pharmaceutical industry use of key opinion leaders (KOLs).

Methods

We conducted a retrospective qualitative review of the first 503 opioid industry documents publicly released, which are held at the University of California, San Francisco Opioid Industry Document Archive (OIDA). We reviewed documents including legal rulings, correspondences, witness statements, clinical studies, and corporate communications for relevance and coded them by themes.

Results

Between 2001 and 2019, pharmaceutical companies including Janssen, Purdue Pharma, and Cephalon identified, recruited and developed individuals they referred to as “Key Opinion Leaders,” (KOLs) that they recognized could reach strategic audiences to influence prescriber behaviors. Pharmaceutical companies identified KOLs through a variety of sources ranging from partnerships with PR firms to social media analysis and congressional and regulatory sources. Companies recruited KOLs through various methods including surveys to identify common names identified by physicians, internal rankings based on friendliness, and opioid prescribing behaviors. Companies employed KOLs as speakers at conferences for branded opioid products, authors of research articles in support of prescription opioids, and consultants regarding marketing strategies.

Conclusions

KOLs were employed by the pharmaceutical industry to leverage their reputations in the service of encouraging healthcare providers to prescribe more opioids. It is critical to ensure that researchers and leaders in the medical field are aware and critical of pharmaceutical corporate profit-led biases and are free from conflicts of interest to avoid inappropriate prescribing and minimize adverse outcomes for patients.
目的:从2000年到2014年,处方阿片类药物相关死亡增加了200%。关于制药公司用于销售处方阿片类药物的渠道的研究有限。在本研究中,我们调查了制药行业对关键意见领袖(kol)的使用。方法对美国加州大学旧金山分校阿片类药物行业文件档案馆(OIDA)首次公开发布的503份阿片类药物行业文件进行回顾性定性分析。我们审阅了相关文件,包括法律裁决、信函、证人陈述、临床研究和公司通讯,并按主题对其进行编码。2001年至2019年期间,包括杨森(Janssen)、普渡制药(Purdue Pharma)和Cephalon在内的制药公司确定、招募并培养了他们称之为“关键意见领袖”(kol)的个人,他们认为这些人可以接触到战略受众,影响处方者的行为。制药公司通过各种渠道确定kol,从与公关公司的合作伙伴关系到社交媒体分析以及国会和监管机构的来源。公司通过各种方法招募kol,包括通过调查确定医生识别的常见名称,基于友好度的内部排名,以及阿片类药物处方行为。公司聘请kol在品牌阿片类产品会议上发言,撰写支持处方阿片类药物的研究文章,以及担任营销策略顾问。结论:制药行业利用kol的声誉来鼓励医疗服务提供者开更多的阿片类药物。至关重要的是,要确保医学领域的研究人员和领导人了解并批评制药公司以利润为导向的偏见,避免利益冲突,以避免不当的处方,并尽量减少对患者的不良后果。
{"title":"Pharmaceutical industry use of key opinion leaders to market prescription opioids: A review of internal industry documents","authors":"Brian Gac ,&nbsp;Kgosi Tavares ,&nbsp;Hanna Yakubi ,&nbsp;Hannah Khan ,&nbsp;Dorie E. Apollonio ,&nbsp;Eric Crosbie","doi":"10.1016/j.rcsop.2024.100543","DOIUrl":"10.1016/j.rcsop.2024.100543","url":null,"abstract":"<div><h3>Objective</h3><div>Prescription opioid-related deaths increased by 200 % from 2000 to 2014. There has been limited research regarding channels used by pharmaceutical companies to market prescription opioids. In this study, we investigated pharmaceutical industry use of key opinion leaders (KOLs).</div></div><div><h3>Methods</h3><div>We conducted a retrospective qualitative review of the first 503 opioid industry documents publicly released, which are held at the University of California, San Francisco Opioid Industry Document Archive (OIDA). We reviewed documents including legal rulings, correspondences, witness statements, clinical studies, and corporate communications for relevance and coded them by themes.</div></div><div><h3>Results</h3><div>Between 2001 and 2019, pharmaceutical companies including Janssen, Purdue Pharma, and Cephalon identified, recruited and developed individuals they referred to as “Key Opinion Leaders,” (KOLs) that they recognized could reach strategic audiences to influence prescriber behaviors. Pharmaceutical companies identified KOLs through a variety of sources ranging from partnerships with PR firms to social media analysis and congressional and regulatory sources. Companies recruited KOLs through various methods including surveys to identify common names identified by physicians, internal rankings based on friendliness, and opioid prescribing behaviors. Companies employed KOLs as speakers at conferences for branded opioid products, authors of research articles in support of prescription opioids, and consultants regarding marketing strategies.</div></div><div><h3>Conclusions</h3><div>KOLs were employed by the pharmaceutical industry to leverage their reputations in the service of encouraging healthcare providers to prescribe more opioids. It is critical to ensure that researchers and leaders in the medical field are aware and critical of pharmaceutical corporate profit-led biases and are free from conflicts of interest to avoid inappropriate prescribing and minimize adverse outcomes for patients.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"16 ","pages":"Article 100543"},"PeriodicalIF":1.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142745718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling the complementariness of robotic tablet dispensing machines for elderly care: A bibliometric data analysis 揭示机器人片剂配药机的互补性为老年人护理:文献计量数据分析
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-11-26 DOI: 10.1016/j.rcsop.2024.100545
Sunday Adewale Olaleye , Olaleye Esther Olubunmi , Berhanemeskel Weldegerima Atsbeha , Mulugeta Negash Wodaje
This study conducts a bibliometric analysis of academic papers and conference proceedings related to tablet dispensers, medicine dispensers, and pill dispensers within the framework of Sustainable Development Goal 03: Good Health and Well-Being. The analysis spans literature published between 1997 and 2023. Utilizing the Web of Science database, the study employs keywords such as “tablet dispenser,” “medicine dispenser,” and “pill dispenser” to gather relevant English-language papers classified as Proceeding Papers or Articles. The inclusion and exclusion criteria filtered 79 initial records down to 40, focusing on articles pertinent to SDG 03. Data analysis was performed using the Biblioshiny App through RStudio, examining publication trends, authorship patterns, citation networks, and other bibliometric indicators. The findings reveal a steady increase in research output, moderate citation impact, extensive references, and collaborative authorship, with limited international collaboration. The study underscores the growing interest and research activity in robotic tablet dispensing machines for elderly care while highlighting areas for further global engagement.
本研究在可持续发展目标03:良好健康和福祉的框架内,对与片剂分配器、药品分配器和药丸分配器相关的学术论文和会议记录进行了文献计量学分析。该分析涵盖了1997年至2023年间发表的文献。该研究利用Web of Science数据库,使用“tablet dispenser”、“medicine dispenser”和“pill dispenser”等关键词收集相关的英文论文,分类为“proceed papers”或“Articles”。纳入和排除标准将79条初始记录筛选到40条,重点关注与可持续发展目标03相关的文章。通过RStudio使用Biblioshiny App进行数据分析,检查出版趋势、作者模式、引文网络和其他文献计量指标。研究结果显示,在国际合作有限的情况下,研究产出稳步增长,引用影响适中,广泛的参考文献和合作作者。该研究强调了老年人护理机器人片剂分配机日益增长的兴趣和研究活动,同时强调了进一步全球参与的领域。
{"title":"Unveiling the complementariness of robotic tablet dispensing machines for elderly care: A bibliometric data analysis","authors":"Sunday Adewale Olaleye ,&nbsp;Olaleye Esther Olubunmi ,&nbsp;Berhanemeskel Weldegerima Atsbeha ,&nbsp;Mulugeta Negash Wodaje","doi":"10.1016/j.rcsop.2024.100545","DOIUrl":"10.1016/j.rcsop.2024.100545","url":null,"abstract":"<div><div>This study conducts a bibliometric analysis of academic papers and conference proceedings related to tablet dispensers, medicine dispensers, and pill dispensers within the framework of Sustainable Development Goal 03: Good Health and Well-Being. The analysis spans literature published between 1997 and 2023. Utilizing the Web of Science database, the study employs keywords such as “tablet dispenser,” “medicine dispenser,” and “pill dispenser” to gather relevant English-language papers classified as Proceeding Papers or Articles. The inclusion and exclusion criteria filtered 79 initial records down to 40, focusing on articles pertinent to SDG 03. Data analysis was performed using the Biblioshiny App through RStudio, examining publication trends, authorship patterns, citation networks, and other bibliometric indicators. The findings reveal a steady increase in research output, moderate citation impact, extensive references, and collaborative authorship, with limited international collaboration. The study underscores the growing interest and research activity in robotic tablet dispensing machines for elderly care while highlighting areas for further global engagement.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"17 ","pages":"Article 100545"},"PeriodicalIF":1.8,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142747538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges prescribing and dispensing oral antibiotics with poor palatability for paediatric patients: A qualitative interview study with GPs and pharmacists 挑战处方和配发口服抗生素与不良适口儿科患者:与全科医生和药剂师定性访谈研究
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-11-23 DOI: 10.1016/j.rcsop.2024.100546
Ayat Elgammal , Joseph Ryan , Colin Bradley , Abina Crean , Margaret Bermingham

Background

Poor palatability of antibiotics is a key cause for non-adherence to antibiotic treatment among children. Failure to complete antibiotic treatment because of poor palatability can cause disease recurrence and may contribute to increasing rates of antimicrobial resistance. The aim of this study was to investigate the experience and challenges faced by general practitioners (GPs) and community pharmacists regarding prescribing and dispensing oral liquid antibiotics for children and the impact of poorly palatable antibiotic formulations on patients and the health-system.

Methods

One-to-one semi-structured interviews with GPs and pharmacists were conducted via an online video-conferencing platform. Data were analysed using thematic analysis.

Results

Twenty participants (7 GPs and 13 pharmacists) were interviewed. Three main themes and eight subthemes were identified. Theme 1: challenges reported by GPs and pharmacists included four subthemes; (i) factors affecting prescribing and dispensing antibiotics, (ii) reasons to select poorly palatable antibiotics, (iii) palatability discussion with parents, and (iv) formulation factors affecting oral liquid antibiotic acceptability. Theme 2: the impact of prescribing or dispensing poorly palatable oral liquid antibiotics encompassed two sub themes; (i) patient impact and (ii) health-system impact. Theme 3: overcoming palatability challenges involved two subthemes; (i) raising awareness of flavour and palatability issues among healthcare professionals and (ii) counselling parents while prescribing and before dispensing.

Conclusions

There is a need to increase palatability awareness among healthcare professionals and parents. The development of more palatable oral liquid formulations can play a role in improving prescribing and medicines taking practices.
抗生素的适口性差是儿童不坚持抗生素治疗的一个关键原因。由于适口性差而未能完成抗生素治疗可导致疾病复发,并可能导致抗菌素耐药性增加。本研究的目的是调查全科医生(gp)和社区药剂师在为儿童开处方和配发口服液体抗生素方面的经验和面临的挑战,以及不良适口抗生素配方对患者和卫生系统的影响。方法通过网络视频会议平台对全科医生和药师进行一对一半结构化访谈。采用专题分析对数据进行分析。结果共访谈20人,其中全科医生7人,药师13人。确定了三个主要主题和八个次级主题。主题1:全科医生和药剂师报告的挑战包括四个分主题;(i)影响抗生素处方和分配的因素,(ii)选择不太可口的抗生素的原因,(iii)与家长讨论适口性,以及(iv)影响口服液体抗生素可接受性的配方因素。主题2:处方或配发不可口的口服液抗生素的影响包括两个子主题;(i)对患者的影响和(ii)对卫生系统的影响。主题3:克服适口性挑战包括两个子主题;(i)提高医护专业人员对口味和口味问题的认识,以及(ii)在开处方时和配药前向家长提供咨询。结论卫生保健专业人员和家长需要提高适口性意识。开发更可口的口服液配方可以在改进处方和服药方面发挥作用。
{"title":"Challenges prescribing and dispensing oral antibiotics with poor palatability for paediatric patients: A qualitative interview study with GPs and pharmacists","authors":"Ayat Elgammal ,&nbsp;Joseph Ryan ,&nbsp;Colin Bradley ,&nbsp;Abina Crean ,&nbsp;Margaret Bermingham","doi":"10.1016/j.rcsop.2024.100546","DOIUrl":"10.1016/j.rcsop.2024.100546","url":null,"abstract":"<div><h3>Background</h3><div>Poor palatability of antibiotics is a key cause for non-adherence to antibiotic treatment among children. Failure to complete antibiotic treatment because of poor palatability can cause disease recurrence and may contribute to increasing rates of antimicrobial resistance. The aim of this study was to investigate the experience and challenges faced by general practitioners (GPs) and community pharmacists regarding prescribing and dispensing oral liquid antibiotics for children and the impact of poorly palatable antibiotic formulations on patients and the health-system.</div></div><div><h3>Methods</h3><div>One-to-one semi-structured interviews with GPs and pharmacists were conducted via an online video-conferencing platform. Data were analysed using thematic analysis.</div></div><div><h3>Results</h3><div>Twenty participants (7 GPs and 13 pharmacists) were interviewed. Three main themes and eight subthemes were identified. Theme 1: <em>challenges reported by GPs and pharmacists</em> included four subthemes; (i) factors affecting prescribing and dispensing antibiotics, (ii) reasons to select poorly palatable antibiotics, (iii) palatability discussion with parents, and (iv) formulation factors affecting oral liquid antibiotic acceptability. Theme 2: <em>the impact of prescribing or dispensing poorly palatable oral liquid antibiotics</em> encompassed two sub themes; (i) patient impact and (ii) health-system impact. Theme 3: <em>overcoming palatability challenges</em> involved two subthemes; (i) raising awareness of flavour and palatability issues among healthcare professionals and (ii) counselling parents while prescribing and before dispensing.</div></div><div><h3>Conclusions</h3><div>There is a need to increase palatability awareness among healthcare professionals and parents. The development of more palatable oral liquid formulations can play a role in improving prescribing and medicines taking practices.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"17 ","pages":"Article 100546"},"PeriodicalIF":1.8,"publicationDate":"2024-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142747537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-dispensed prescriptions – A nationwide descriptive study 非配药处方 - 一项全国性的描述性研究
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-11-16 DOI: 10.1016/j.rcsop.2024.100541
Heini Kari , Fredriikka Nurminen , Hanna Rättö , Hanna Koskinen

Background

Medication non-adherence is associated with suboptimal health outcomes, higher mortality, and increased healthcare costs.

Objective

The aim of this study was to estimate the number and share of non-dispensed prescriptions at a national level and in specific patient and medicine subgroups.

Methods

The study was a nationwide retrospective register-based study. The data consisted of prescriptions prescribed in Finland in 2020 and dispensed between 2020 and 2022. A prescription was considered non-dispensed if it had not been dispensed within the two-year validity period. For each prescription, information on the patient's birth date, sex, and income as well as details of the prescribed medicine and physician's employment sector (public/private) were collected. Distributions and odds ratios (ORs) with corresponding 95 % confidence intervals (CI) were used in the analyses.

Results

Of the 26 million prescriptions, 13.3 % were never filled. Over 1.7 million people (43.3 % of all people with prescriptions issued in 2020) had at least one non-dispensed prescription. The share of non-dispensed prescriptions was lower in men than women (12.9 % vs. 13.5 %; OR:0.95; CI:0.95–0.95). Compared to the youngest age group, the share of non-dispensed prescriptions was lower in the older age groups. The lowest share of non-dispensed medicines was in antineoplastic and immunomodulating agents (7.8 %) and in cardiovascular system medicines (8.1 %), whereas the highest was in dermatologicals (20.2 %). The proportion of non-dispensed prescriptions varied between medicine groups, from 5 % for thyroid therapy to 38 % for other nervous system drugs. The most frequently non-dispensed medications were paracetamol, ibuprofen, and salbutamol.

Conclusion

The share and number of non-dispensed prescriptions varied across therapeutic areas, medicine groups, active pharmaceutical ingredients, and patient groups. Healthcare professionals should avoid unnecessary prescribing and improve medication adherence to ensure safer and more effective care.
背景不遵医嘱用药与不理想的健康结果、较高的死亡率和增加的医疗成本有关。方法该研究是一项基于登记的全国性回顾性研究。数据包括 2020 年在芬兰开具的处方和 2020 年至 2022 年期间配发的处方。在两年有效期内未配发的处方被视为未配发处方。对于每张处方,我们都收集了患者的出生日期、性别、收入、处方药物的详细信息以及医生的工作部门(公立/私立)等信息。结果 在 2,600 万张处方中,13.3% 的处方从未开过。超过 170 万人(占 2020 年开具处方总人数的 43.3%)拥有至少一张非处方。男性的非处方比例低于女性(12.9% 对 13.5%;OR:0.95;CI:0.95-0.95)。与最年轻的年龄组相比,较大年龄组的非处方药比例较低。抗肿瘤和免疫调节剂(7.8%)和心血管系统药物(8.1%)的非处方药比例最低,而皮肤科药物(20.2%)的非处方药比例最高。不同药品组的非处方比例各不相同,从甲状腺治疗药物的 5%到其他神经系统药物的 38%不等。结论不同治疗领域、不同药品组别、不同活性药物成分和不同患者群体的非处方比例和数量各不相同。医护人员应避免不必要的处方并提高用药依从性,以确保提供更安全、更有效的护理。
{"title":"Non-dispensed prescriptions – A nationwide descriptive study","authors":"Heini Kari ,&nbsp;Fredriikka Nurminen ,&nbsp;Hanna Rättö ,&nbsp;Hanna Koskinen","doi":"10.1016/j.rcsop.2024.100541","DOIUrl":"10.1016/j.rcsop.2024.100541","url":null,"abstract":"<div><h3>Background</h3><div>Medication non-adherence is associated with suboptimal health outcomes, higher mortality, and increased healthcare costs.</div></div><div><h3>Objective</h3><div>The aim of this study was to estimate the number and share of non-dispensed prescriptions at a national level and in specific patient and medicine subgroups.</div></div><div><h3>Methods</h3><div>The study was a nationwide retrospective register-based study. The data consisted of prescriptions prescribed in Finland in 2020 and dispensed between 2020 and 2022. A prescription was considered non-dispensed if it had not been dispensed within the two-year validity period. For each prescription, information on the patient's birth date, sex, and income as well as details of the prescribed medicine and physician's employment sector (public/private) were collected. Distributions and odds ratios (ORs) with corresponding 95 % confidence intervals (CI) were used in the analyses.</div></div><div><h3>Results</h3><div>Of the 26 million prescriptions, 13.3 % were never filled. Over 1.7 million people (43.3 % of all people with prescriptions issued in 2020) had at least one non-dispensed prescription. The share of non-dispensed prescriptions was lower in men than women (12.9 % vs. 13.5 %; OR:0.95; CI:0.95–0.95). Compared to the youngest age group, the share of non-dispensed prescriptions was lower in the older age groups. The lowest share of non-dispensed medicines was in antineoplastic and immunomodulating agents (7.8 %) and in cardiovascular system medicines (8.1 %), whereas the highest was in dermatologicals (20.2 %). The proportion of non-dispensed prescriptions varied between medicine groups, from 5 % for thyroid therapy to 38 % for other nervous system drugs. The most frequently non-dispensed medications were paracetamol, ibuprofen, and salbutamol.</div></div><div><h3>Conclusion</h3><div>The share and number of non-dispensed prescriptions varied across therapeutic areas, medicine groups, active pharmaceutical ingredients, and patient groups. Healthcare professionals should avoid unnecessary prescribing and improve medication adherence to ensure safer and more effective care.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"16 ","pages":"Article 100541"},"PeriodicalIF":1.8,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142704765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Exploratory research in clinical and social pharmacy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1